Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections

Clinical trial NCT01015014 · COMPLETED

Trial details

NCT number: NCT01015014
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gram-negative Bacterial Infection

Start date: 2009-11-05
Primary completion: 2010-05-13
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.